Heart Failure Society of America 12th Annual Scientific Meeting to Focus on Optimal Treatment, Innovative New Approaches, New Insights into Mechanisms and Social Issues



    
    September 21-24, 2008, Metro Toronto Convention Center, Toronto, Ontario,
    Canada

    National and International Health Care Professionals Will Convene to
Learn,
    Discuss and Debate New Research Findings and Treatment Strategies for
Heart
    Failure Patients

    
    TORONTO, Sept. 16 /CNW/ -- The Heart Failure Society of America's
(HFSA)(http://www.hfsa.org) 12th Annual Scientific Meeting convenes Sunday,
September 21, 2008 at the Metro Toronto Convention Center in Toronto, Canada
(http://www.hfsa.org/location.asp).  This three-day meeting -- a forum for
heart failure specialists to present research findings and advances in
treatment -- will address emerging trends in research and new developments in
the approach to treating patients with this condition.
    The scientific program will kick off with an opening plenary session,
"Aerobiology, The Environment and Cardiovascular Health," on Monday, September
22 at 8:10 a.m.  Simultaneous sessions will include presentations by national
and international heart failure experts, scientists, and allied health care
professionals.  Many will focus on the progressive treatments for heart
failure and the increased risk faced by patients.
    "This year's conference will present exciting new information about the
causes and treatment of heart failure, and the important socio-economic issues
surrounding this condition," said Dr. Barry Greenberg, HFSA President, and
Professor of Medicine, Director, Heart Failure/Cardiac Transplantation Program
at The University of California, San Diego School of Medicine.
    Other scientific meeting sessions that address issues relating to heart
failure include:
    
    -- Particulate Matter Air Pollution and Heart Health
    -- Athletes and Sudden Death Syndromes
    -- Naturoceuticals and Heart Failure: Innocuous and Harmful?
    -- Hope in the Hopeless Situation: Palliative Care
    -- Nitric Oxide as a unique signaling molecule in physiology
    -- Guideline updates on management of heart failure patients receiving
       cancer chemotherapy
    -- Update on the genetic evaluation of heart failure
    
    Late Breaking Clinical Trials to be presented that address issues
relating to heart failure include:
    -- SADHART Trial: Safety and Efficacy of Sertraline for Depression in
Patients with Chronic Heart Failure
    -- PARTNERS HF: Multi-Site Program to Access and Review Trending
Information and Evaluate Correlation to Symptoms in Patients with Heart
Failure
    For a complete list of annual meeting sessions or for details on
attending the conference, call (617) 226-7198 or visit www.hfsa.org and click
on Annual Scientific Meeting. There is no registration fee for accredited
journalists. Interview areas will be available on-site in addition to a
fully-staffed press room with phone and internet accessibility.
    
    About Heart Failure
    
    Heart failure is a progressive condition in which the heart muscle
becomes weakened after it is injured from heart attack or high blood pressure
and gradually loses its ability to pump enough blood to supply the body's
needs. Many people are not aware they have heart failure because the symptoms
are often mistaken for signs of getting older. Heart failure affects from 4.6
to 4.8 million individuals in the United States. Demographic and clinical
evidence strongly suggest the prevalence of heart failure will increase
throughout the next decade. Ten to 15 years ago heart failure was considered a
"death sentence;" however, recent advances in treatment have shown that early
diagnosis and proper care in early stages of the condition are key to slowing,
stopping or in some cases reversing progression, improving quality of life,
and extending life expectancy. For more information on heart failure, please
visit www.abouthf.org.
    
    About the Heart Failure Society of America
    
    The Heart Failure Society of America (HFSA) is a nonprofit educational
organization, founded in 1994 as the first organized association of heart
failure experts. Today HFSA has over 1,700 members and provides a forum for
all those interested in heart function, heart failure research and patient
care. The Society also serves as a resource for governmental agencies (FDA,
NIH, NHLBI, CMS). The HFSA Annual Scientific Meeting is designed to highlight
recent advances in the development of strategies to address the complex
epidemiological, clinical and therapeutic issues of heart failure. Additional
information on HFSA can be found at www.hfsa.org.




For further information:

For further information: Kaitlyn Siner, +1-617-226-7192, or cell,
+1-401-339-0954, ksiner@bellpottingerusa.com, or Ben Hendricks,
+1-617-226-7183, or cell, +1-919-522-2978, bhendricks@bellpottingerusa.com,
both for The Heart Failure Society of America Web Site: http://www.hfsa.org  
              http://www.abouthf.org                
http://www.hfsa.org/location.asp

Organization Profile

THE HEART FAILURE SOCIETY OF AMERICA

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890